| Prospective Observational Cohort HIV & STI Study in Europe (NCT03866759) | Hendrik Streeck | 2019-04-24 |
| A Stigma Reduction Intervention at Time of Entry Into Antenatal Care to Improve PMTCT Services in Tanzania (NCT03600142) | University of Utah | 2019-04-08 |
| More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents (NCT03497676) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-04-03 |
| HBV/HCV/HIV in Belgian Prisons (NCT04366492) | Hasselt University | 2019-04-01 |
| Raltegravir One Thousand Two Hundred vs Darunavir-cb in Immnunosupressed Patients: ROTDIP Study (NCT03842488) | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 2019-04-01 |
| Digital Health Promotion in Iringa, Tanzania (NCT03808597) | University of Oslo | 2019-04-01 |
| The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE (NCT03635788) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-03-28 |
| HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study (NCT03560258) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-03-26 |
| HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals (NCT03485963) | Catherine Bollard | 2019-03-21 |
| Antiretroviral Therapy for Acute HIV Infection (NCT03877536) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2019-03-17 |
| Study on the Response to Tetanus Vaccination of People Living With HIV (NCT03853681) | Centre Hospitalier de Niort | 2019-03-11 |
| Reducing Post-Hospital Mortality in HIV-infected Adults in Tanzania (NCT03858998) | Weill Medical College of Cornell University | 2019-03-05 |
| Role of PLA2G1B During HIV Infection (NCT04208711) | Diaccurate SAS | 2019-03-01 |
| Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women (NCT03789513) | ANRS, Emerging Infectious Diseases | 2019-03-01 |
| Effects of a Nurse-delivered Cognitive Behaviour Therapy on Adherence and Depressive Symptoms in HIV Infected Persons of South Korea (NCT03823261) | Yonsei University | 2019-03-01 |
| Isoprinosine in HIV Patients With Viral Load > 50 y < 200 Copies/mL (NCT03883334) | Universidad San Francisco de Quito | 2019-02-28 |
| Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population (NCT03682939) | St George's, University of London | 2019-02-21 |
| Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIV (NCT03141060) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-02-18 |
| Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid (NCT04062253) | Hospital Universitario Infanta Leonor | 2019-02-15 |
| Study to Evaluate the Effect of GSK3640254 on the Pharmacokinetics of Tenofovir Alafenamide/Emtricitabine (NCT03836729) | ViiV Healthcare | 2019-02-11 |
| A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults (NCT03784079) | ViiV Healthcare | 2019-01-31 |
| Study to Evaluate the Pharmacokinetic (PK) Interactions Between GSK3640254 and Dolutegravir (DTG) (NCT03816696) | ViiV Healthcare | 2019-01-23 |
| eTest: Real-time, Remote Monitoring System for Home-based HIV Testing Among High-risk Men Who Have Sex With Men (NCT03654690) | Brown University | 2019-01-23 |
| Simplified Monitoring Myanmar SM2 Study (NCT04113629) | Kirby Institute | 2019-01-22 |
| Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants (NCT03735849) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-18 |
| Optimisation of Care in Vulnerable HIV Infected Individuals (NCT03799276) | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | 2019-01-15 |
| Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population (NCT03593655) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-14 |
| RA Effect on Cell Surface Molecules in Vivo (NCT03753867) | Ottawa Hospital Research Institute | 2019-01-07 |
| Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir (NCT03670355) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-02 |
| Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure (NCT03758625) | Sharon Riddler | 2019-01-02 |
| Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected Adults (NCT03505060) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-01 |
| Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus (NCT03618056) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-12-19 |
| Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers (NCT05204121) | Viriom | 2018-12-18 |
| Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) in Combo Tablet for Patients Receiving Atripla With Viral Suppression in Taiwan (NCT03595709) | Yu-Jay Corp. | 2018-12-06 |
| A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c) (NCT03685500) | Fundacion SEIMC-GESIDA | 2018-12-04 |
| Management by Individual Cognitive Remediation of Cognitive Disorders of HIV Infected Patients (NCT03639818) | Assistance Publique Hopitaux De Marseille | 2018-12-01 |
| Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population (NCT03702998) | Chinese University of Hong Kong | 2018-12-01 |
| Getting to Zero: Safer Conception Programming Among HIV Sero-different Couples in Uganda (NCT03895619) | Simon Fraser University | 2018-11-26 |
| PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects (NCT03581305) | National Institutes of Health Clinical Center (CC) | 2018-11-20 |
| Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany (NCT03754803) | ViiV Healthcare | 2018-11-08 |
| B/F/TAF Ease of Swallowability Trial (NCT04600687) | Henry Ford Health System | 2018-11-06 |
| Dysbiosis Impact on Lung Disease in HIV (NCT04155684) | University of Pittsburgh | 2018-11-01 |
| A Clinical Trial to Evaluate the Immunogenicity of the Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017 (NCT03626467) | Fundacion SEIMC-GESIDA | 2018-10-15 |
| OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings (NCT03651453) | Yale University | 2018-10-15 |
| Proviral DNA as a Target for HIV-1 Resistance Analysis (NCT04088916) | University of Chile | 2018-10-15 |
| Effect of a Psychological Intervention on Antiretroviral Therapy and Mental Health Outcomes in HIV-positive Adults in Zimbabwe (NCT03704805) | University of Bern | 2018-10-05 |
| Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse (NCT03577301) | Florida State University | 2018-10-04 |
| Stimulant Use and Methylation in HIV (NCT05916989) | Florida International University | 2018-09-30 |
| Immunogenetic Modulators of Mucosal Protection From HIV-1 (NCT03701802) | University of Washington | 2018-09-27 |
| Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study (NCT03639311) | ViiV Healthcare | 2018-09-24 |
| Poor Quality of Life Associated With Traditional Chinese Medicine Constitution in HIV-infected Men Who Have Sex With Men (NCT05299775) | Taipei City Hospital | 2018-09-21 |
| Imaging Immune Activation in HIV by PET-MR (NCT03684655) | CellSight Technologies, Inc. | 2018-09-21 |
| Secondary Distribution of HIV Self-tests Through Antenatal Care Clinic Attendees and Index Clients (NCT03705611) | London School of Hygiene and Tropical Medicine | 2018-09-12 |
| Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV (NCT04165200) | Hospital Universitario Dr. Jose E. Gonzalez | 2018-09-06 |
| Vedolizumab Treatment in HIV-Infected Subjects Without Previous Antiretroviral Therapy (NCT03577782) | Hospitales Universitarios Virgen del Rocío | 2018-09-01 |
| HIV Pre-exposure Prophylaxis Implementation Study in South Korea (NCT04583267) | Yonsei University | 2018-08-28 |
| Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy (NCT03208231) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-08-06 |
| Liver Steatosis and Stiffness in HIV (NCT03599882) | Chang Gung Memorial Hospital | 2018-08-01 |
| Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV (NCT03664817) | Emory University | 2018-07-26 |
| Regional Bone Turnover Using 18F-fluoride-PET/CT in HIV-1-infected Men: PETRAM Study (NCT03405012) | University College, London | 2018-07-24 |
| The Effectiveness of SMS in Improving Antiretroviral Medication Adherence Among Adolescents Living With HIV in Nigeria (NCT03394391) | Dr. Olumide ABIODUN | 2018-07-05 |
| Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum (NCT03386578) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-03 |
| Evaluating the Pharmacokinetics, Safety, and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents (NCT03332095) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-02 |
| Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1 (NCT03518060) | ViiV Healthcare | 2018-06-25 |
| Evaluating the Safety and Pharmacokinetics of PC-1005 Administered Rectally to HIV-1 Seronegative Adults (NCT03408899) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-06-19 |
| A Study to Compare the Relative Bioavailability of Two Different Formulations of GSK3640254 (NCT03575962) | ViiV Healthcare | 2018-06-18 |
| Partners PrEP Program (NCT03586128) | University of Washington | 2018-06-08 |
| (mo)BETTA Trial in Transwomen for Optimization of ART (NCT03348163) | The University of Texas Health Science Center, Houston | 2018-06-06 |
| A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM (NCT03167606) | Columbia University | 2018-06-01 |
| HIV and STIs Clinical Study in Germany (NCT03884816) | Hendrik Streeck | 2018-06-01 |
| Assessing the Effectiveness and Feasibility of Voluntary Assisted Partner Notification Services (NCT03944395) | Lighthouse Trust | 2018-05-21 |
| Evaluation of Presumptive Periodic Treatment (PPT) of Sexually Transmitted Infections (STIs) (NCT04036318) | National Institute for Medical Research, Tanzania | 2018-05-14 |
| Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs (NCT03767374) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2018-05-11 |
| Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (NCT03393468) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-05-10 |
| Spanish Cohort of Patients with HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function (NCT03558438) | Fundacion SEIMC-GESIDA | 2018-05-07 |
| The Role of Probiotics in HIV Patients With Immunological Non-Responder (NCT03568812) | Indonesia University | 2018-05-07 |
| Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen (NCT03333083) | Judit Pich | 2018-05-03 |
| Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM (NCT03311945) | Judit Pich | 2018-05-02 |
| Alignment of PrEP Use With HIV Risk in Young Women and Men (NCT04664998) | University of Washington | 2018-05-01 |
| Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) (NCT03207945) | University of California, San Francisco | 2018-04-30 |
| Body Compartment Pharmacokinetics of Anti- Retroviral Agents That May be Used for Future HIV Post- Exposure Prophylaxis. (NCT03472963) | Emory University | 2018-04-27 |
| Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors (NCT03382834) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-04-26 |
| Drug-drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly Patients (NCT03515772) | Centre Hospitalier Universitaire Vaudois | 2018-04-23 |
| Improving HIV/Tuberculosis Outcomes in Irkutsk (NCT03819374) | University of Virginia | 2018-04-15 |
| A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression (NCT03693508) | Fundacion SEIMC-GESIDA | 2018-04-13 |
| Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers (NCT03892161) | University of Cape Town | 2018-04-12 |
| Triggered Escalating Real-time Adherence (TERA) Intervention (NCT03292432) | University of North Carolina, Chapel Hill | 2018-04-12 |
| A Safety, Tolerability, Acceptability, and Pharmacokinetic (PK) Study of Cabotegravir (CAB) in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Chinese Men (NCT03422172) | ViiV Healthcare | 2018-04-10 |
| PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection (NCT03239899) | National Institute of Neurological Disorders and Stroke (NINDS) | 2018-04-09 |
| Same-Day Antiretroviral Therapy Initiation (NCT04032028) | Thai Red Cross AIDS Research Centre | 2018-04-01 |
| Reducing HIV Vulnerability Through A Multilevel Life Skills Intervention For Adolescent Men (NCT03155841) | University of Pennsylvania | 2018-03-23 |
| Optimization of Antiretroviral Therapy (NCT02935075) | Shanghai Public Health Clinical Center | 2018-03-05 |
| Dosing of Tenofovir and Efavirenz in Antiretroviral Therapy (NCT02945163) | Shanghai Public Health Clinical Center | 2018-03-05 |
| Gut Microbiota Changes of HIV Patients Before and After One Year of ART (NCT04297501) | Peking Union Medical College Hospital | 2018-03-01 |
| Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected Adults (NCT03387150) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-02-28 |
| An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients. (NCT03517631) | Shanghai Public Health Clinical Center | 2018-02-27 |
| To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers (NCT03441984) | ViiV Healthcare | 2018-02-26 |
| Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants (NCT03048422) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-01-19 |
| Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO) (NCT03446573) | ViiV Healthcare | 2018-01-18 |
| Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO) (NCT03435146) | The Aurum Institute NPC | 2018-01-18 |